We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Companies have yet to provide investors with convincing post-pandemic strategies
Oxford university shot expected to deliver ‘sufficient’ supply for all at-risk infants
Katalin Karikó and Drew Weissman praised for role in ‘unprecedented rate of development’ of coronavirus jabs
The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain
Economic and political fallout from war distracts governments from health threats
Victims still await compensation from a case of shocking government indifference, professional malpractice and commercial greed
Report shows 300% increase in demand for GLP-1 weight loss and diabetes drugs
The latest findings build on experiments from over a century ago
Brussels launches talks for mRNA jabs to augment existing contract with BioNTech/Pfizer
Big-selling molnupiravir treatment produces permanent mutations that can be passed from patient to patient
Biobank deadlock is a symptom of the UK’s ailing innovation sector
Cambridge university study contradicts common belief in psychology that it is better to talk about distressing ideas and memories
First example of artificial intelligence helping to accelerate diagnosis of diseases caused by genetic variants
Tedros Adhanom Ghebreyesus says health body is ready to send second mission as Omicron variants drive rise in cases
Neither organisations nor people can learn from their errors if they deny mistakes ever happened
Climate change helps the spread of infectious diseases. Plus: rise in fungal infections highlights risks of antimicrobial resistance; Sydney shows how to almost eliminate HIV transmission; wait goes on for effective Long Covid treatments
Unlike the vaccine race, there is limited funding to treat a condition that is often debilitating
Huge resources devoted to examining links with illness
Experts say joint effort by clinicians, activists and politicians to deploy preventive tools shows how effective they can be
Policymakers are failing to address the likelihood of another pandemic
Leaders must treat these risks as existential — one of very few threats that can change the world in days
Illnesses such as cancer and heart disease supplant likes of HIV
Drug resistance is not just a problem with bacteria
Despite progress on a flu jab, the biotech group will be lossmaking for the next three years
Trial finds latest version elicited better immune response than existing jabs
International Edition
